Search
Passage Bio Inc
PASGAdd to Watchlist
4.470USD
-0.020-0.45%
Close 07-31 16:00（ET）Quotes delayed by 15 min
14.23MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
3
analysts
Hold
Current Rating
15.500
Target Price
+242.92%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Passage Bio Inc
PASG
3
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Passage Bio Inc's price target?
Analysts forecast that Passage Bio Inc's price target is USD 53.50, with the highest forecast at USD 120.00 and the lowest forecast at USD 10.00.
How have Passage Bio IncPASG's recent earnings per share performed?
The market expectation was USD -2.36, while Passage Bio IncPASG's earnings per share (EPS) for the previous quarter was USD -4.08. EPS for the next quarter is expected at USD -2.65.
What is the analyst rating for Passage Bio Inc?
Based on the ratings of Passage Bio Inc's stock from 3 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.